|
1
|
Olopade OI, Grushko TA, Nanda R and Huo D:
Advances in breast cancer: pathways to personalized medicine. Clin
Cancer Res. 14:7988–7999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rohan TE, Wong LJ, Wang T, et al: Do
alterations in mitochondrial DNA play a role in breast
carcinogenesis? J Oncol. 2010:6043042010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Czarnecka AM, Krawczyk T, Zdrozny M, et
al: Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism
(A10398G) and sporadic breast cancer in Poland. Breast Cancer Res
Treat. 121:511–518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Darvishi K, Sharma S, Bhat AK, et al:
Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup
N a risk for breast and esophageal cancer. Cancer Lett.
249:249–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Canter JA, Kallianpur AR, Parl FF and
Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive
breast cancer in African-American women. Cancer Res. 65:8028–8033.
2005.
|
|
6
|
Wallace DC: Mitochondria as chi. Genetics.
179:727–735. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai RK, Leal SM, Covarrubias D, et al:
Mitochondrial genetic background modifies breast cancer risk.
Cancer Res. 67:4687–4694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aikhionbare FO, Khan M, Carey D, et al: Is
cumulative frequency of mitochondrial DNA variants a biomarker for
colorectal tumor progression? Mol Cancer. 3:302004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Datta S, Majumder M, Biswas NK, et al:
Increased risk of oral cancer in relation to common Indian
mitochondrial polymorphisms and autosomal GSTP1 locus. Cancer.
110:1991–1999. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van der Walt JM, Nicodemus KK, Martin ER,
et al: Mitochondrial polymorphisms significantly reduce the risk of
Parkinson disease. Am J Hum Genet. 72:804–811. 2003.PubMed/NCBI
|
|
11
|
van der Walt JM, Dementieva YA, Martin ER,
et al: Analysis of European mitochondrial haplogroups with
Alzheimer disease risk. Neurosci Lett. 365:28–32. 2004.PubMed/NCBI
|
|
12
|
Mancuso M, Conforti FL, Rocchi A, et al:
Could mitochondrial haplogroups play a role in sporadic amyotrophic
lateral sclerosis? Neurosci Lett. 371:158–162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giacchetti M, Monticelli A, De Biase I, et
al: Mitochondrial DNA haplogroups influence the Friedreich’s ataxia
phenotype. J Med Genet. 41:293–295. 2004.PubMed/NCBI
|
|
14
|
Wells GA, Shea B, O’Connell D, et al: The
Newcastle-Ottawa Scale (NOS) for assessing the quality of
nonrandomised studies in meta-analyses. Available from: URL:
http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspuri.
Accessed on November 26, 2011.
|
|
15
|
Covarrubias D, Bai RK, Wong LJ and Leal
SM: Mitochondrial DNA variant interactions modify breast cancer
risk. J Hum Genet. 53:924–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang H, Shen L, Chen T, et al: Cancer
type-specific modulation of mitochondrial haplogroups in breast,
colorectal and thyroid cancer. BMC Cancer. 10:4212010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pezzotti A, Kraft P, Hankinson SE, et al:
The mitochondrial A10398G polymorphism, interaction with alcohol
consumption, and breast cancer risk. PLoS One. 4:e53562009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Setiawan VW, Chu LH, John EM, et al:
Mitochondrial DNA G10398A variant is not associated with breast
cancer in African-American women. Cancer Genet Cytogenet.
181:16–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brandon M, Baldi P and Wallace DC:
Mitochondrial mutations in cancer. Oncogene. 25:4647–4662. 2006.
View Article : Google Scholar
|
